NCT02656797View on ClinicalTrials.gov

Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

June 1, 2021

Study Completion Date

October 1, 2021

Conditions
Leishmaniasis
Interventions
DRUG

Topical Amphotericin-B 0.4% liposomal gel

Topical Amphotericin-B 0.4% liposomal gel

Trial Locations (1)

Unknown

Soroka University Medical Center, Beersheba

All Listed Sponsors
lead

Soroka University Medical Center

OTHER

NCT02656797 - Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis | Biotech Hunter | Biotech Hunter